Abstract:Background The global pandemics of severe acute respiratory syndrome, Middle East respiratory syndrome, and COVID-19 have caused unprecedented crises for public health. Coronaviruses are constantly evolving, and it is unknown which new coronavirus will emerge and when the next coronavirus will sweep across the world. Knowledge graphs are expected to help discover the pathogenicity and transmission mechanism of viruses. Objective The aim of this study was to discover potential targets and candidate drugs to repurpose for coronaviruses through a knowledge graph–based approach. Methods We propose a computational and evidence-based knowledge discovery approach to identify potential targets and candidate drugs for coronaviruses from biomedical literature and well-known knowledge bases. To organize the semantic triples extracted automatically from biomedical literature, a semantic conversion model was designed. The literature knowledge was associated and integrated with existing drug and gene knowledge through semantic mapping, and the coronavirus knowledge graph (CovKG) was constructed. We adopted both the knowledge graph embedding model and the semantic reasoning mechanism to discover unrecorded mechanisms of drug action as well as potential targets and drug candidates. Furthermore, we have provided evidence-based support with a scoring and backtracking mechanism. Results The constructed CovKG contains 17,369,620 triples, of which 641,195 were extracted from biomedical literature, covering 13,065 concept unique identifiers, 209 semantic types, and 97 semantic relations of the Unified Medical Language System. Through multi-source knowledge integration, 475 drugs and 262 targets were mapped to existing knowledge, and 41 new drug mechanisms of action were found by semantic reasoning, which were not recorded in the existing knowledge base. Among the knowledge graph embedding models, TransR outperformed others (mean reciprocal rank=0.2510, Hits@10=0.3505). A total of 33 potential targets and 18 drug candidates were identified for coronaviruses. Among them, 7 novel drugs (ie, quinine, nelfinavir, ivermectin, asunaprevir, tylophorine, Artemisia annua extract, and resveratrol) and 3 highly ranked targets (ie, angiotensin converting enzyme 2, transmembrane serine protease 2, and M protein) were further discussed. Conclusions We showed the effectiveness of a knowledge graph–based approach in potential target discovery and drug repurposing for coronaviruses. Our approach can be extended to other viruses or diseases for biomedical knowledge discovery and relevant applications.

Using TransR to Enhance Drug Repurposing Knowledge Graph for COVID-19 and Its Complications

Drug Repurposing for the Treatment of COVID‐19: A Knowledge Graph Approach

Drug repurposing for COVID-19 using graph neural network and harmonizing multiple evidence

Knowledge Graph-Based Approaches to Drug Repurposing for COVID-19

Repurpose Open Data to Discover Therapeutics for COVID-19 Using Deep Learning

Network reinforcement driven drug repurposing for COVID-19 by exploiting disease-gene-drug associations

Drug repurposing for COVID-19 via knowledge graph completion

Drug-CoV: a drug-origin knowledge graph discovering drug repurposing targeting COVID-19

Analysis of Drug repurposing Knowledge graphs for Covid-19

Dr-COVID: Graph Neural Networks for SARS-CoV-2 Drug Repurposing

Drug Repurposing for COVID-19 Treatment by Integrating Network Pharmacology and Transcriptomics

Molecular-evaluated and explainable drug repurposing for COVID-19 using ensemble knowledge graph embedding

Identification of Therapeutic Drugs Against COVID-19 Through Computational Investigation on Drug Repurposing and Structural Modification

Potential Target Discovery and Drug Repurposing for Coronaviruses: Study Involving a Knowledge Graph–Based Approach

Signaling Repurposable Drug Combinations Against COVID-19 by Developing the Heterogeneous Deep Herb-Graph Method

Network-Based Approach to Repurpose Approved Drugs for COVID-19 by Integrating GWAS and Text Mining Data

Are we there yet? Analyzing scientific research related to COVID-19 drug repurposing

Repurposing Drugs for Infectious Diseases by Graph Convolutional Network with Sensitivity-Based Graph Reduction

Ontological and Bioinformatic Analysis of Anti-Coronavirus Drugs and Their Implication for Drug Repurposing against COVID-19

Network medicine framework for identifying drug-repurposing opportunities for COVID-19

Recent computational drug repositioning strategies against SARS-CoV-2.